Companies are halting studies the moment a positive result arises:
Researchers have discovered a sharp increase in the number of studies that are terminated early and argue that drugmakers are halting trials whenever benefits are discovered – and use the premature results as the basis for license applications. As a result, the researchers claim, drugs that are hailed as breakthroughs could be of less benefit or even cause more harm.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
